Ureas

Tests of experimental antiviral treatment against COVID-19 by the American company "Pfizer" (Pfizer) in the form of a pill have proved so promising that they have been shortened. The reason is that it reduced by 89% the risk of hospitalization or death in adults at risk of developing a severe form of the disease.

Pfizer announced today it has started a mid-to-late-stage study testing its oral antiviral drug for the prevention of Covid-19 infection among those who have been exposed to the virus, news wires reported. The company and its rivals, such as US-based Merck and Swiss Roche, have been racing to develop the first antiviral pill for Covid-19.

A Chinese citizen infected with the new coronavirus showed a dramatic improvement after she was treated with a cocktail of anti-virals used to treat flu and HIV, Thailand's Health Ministry said Sunday.

The 71-year-old patient tested negative for the virus 48 hours after Thai doctors administered the combination, it became clear at a daily briefing at the ministry.

A group of more than 200 scientists and health professionals from around the world issued a statement on June 20 that urged consumers to stop using products that contain two common antimicrobial chemicals. 

A drug discovered more than 100 years ago may hold the key to combating autism symptoms, according to a study.

Researcher Dr Robert Naviaux of the San Diego School of Medicine gave suramin, a drug first developed in 1916, to 10 autistic boys between the ages of five and 14, and noted transformative results.

The first drug to treat low sexual desire in women won approval from U.S. health regulators on Aug. 18, but with a warning about potentially dangerous low blood pressure and fainting side effects, especially when taken with alcohol.